Nucala (mepolizumab) for the Treatment of Hypereosinophilic Syndrome (HES)

Image 1-Nucala (mepolizumab)
Nucala (mepolizumab) is a biologic drug used for the treatment of hypereosinophilic syndrome (HES). Credit: GlaxoSmithKline.